Amanda Acerbi
Company: Janssen
Job title: Precision Medicine Global Director
Seminars:
Chair’s Closing Remarks & End of the 2nd LBx Surveillance & Early Detection Summit 5:30 pm
day: Day Two
Harnessing Microfluidic, Methylation & Fragmentomic Strategies to Characterize Targets for Earlier Detection
Chair: 3:35 pm
day: Day Two
Panel Discussion: Driving Widespread Adoption of Reproducible, Innovative & Clinically Validated LBx Tests to Improve Patient Access through Increased Reimbursements 9:30 am
What are the challenges faced in obtaining reimbursement for LBx tests? How to advise recommendations to improve reimbursement policies for LBx tests used in surveillance? What role does standardization, enhanced evidence generation, and ongoing communication/collaboration between stakeholders play in achieving reimbursements?Read more
day: Day Two
Unifying Screening Frameworks for Multi-Cancer Early Detection & MRD to Enable Clinical Implementation 1:30 pm
day: Day One
Chair’s Closing Remarks & End of Conference Day One 5:00 pm
day: Day One